Moneycontrol PRO
HomeNewsBusinessMarketsClosing Bell: Nifty ends above 9,250 boosted by RIL, Sensex up 199 pts; pharma stocks gain
Live now
auto refresh

Closing Bell: Nifty ends above 9,250 boosted by RIL, Sensex up 199 pts; pharma stocks gain

Buying seen in the pharma, FMCG, energy, IT and infra space, while selling seen in the auto, bank and metal sectors.

May 08, 2020 / 17:10 IST
  • Moneycontrol.com
-->
  • IndexPricesChangeChange%
    Sensex85,712.37447.05 +0.52%
    Nifty 5026,186.45152.70 +0.59%
    Nifty Bank59,777.20488.50 +0.82%
    Nifty 50 26,186.45 152.70 (0.59%)
    Fri, Dec 05, 2025
    Biggest GainerPricesChangeChange%
    Shriram Finance854.9026.75 +3.23%
    Biggest LoserPricesChangeChange%
    Interglobe Avi5,370.50-66.00 -1.21%
    Best SectorPricesChangeChange%
    Nifty PSU Bank8381.75125.05 +1.51%
    Worst SectorPricesChangeChange%
    Nifty Pharma22947.20-11.80 -0.05%


  • May 08, 2020 / 16:47 IST

    Ajit Mishra, VP - Research, Religare Broking:

    The domestic factors viz. COVID-19 cases and disappointing earnings will continue to weigh on the sentiments ahead. In such a scenario, sustainability at higher levels seems difficult. We suggest maintaining extra caution on stock selection and focus more on position management aspects.

  • May 08, 2020 / 16:45 IST

    Shrikant Chouhan, Executive Vice President, Equity Technical Research at Kotak Securities:

    Support for Nifty exists at 9230 and 9170 level. Expect a quick decline to the levels of 9000/8970, in case Nifty breaks the level of 9230 followed by 9170. Resistance has shifted to 9400/9450 from the levels of 9550/9600.

  • May 08, 2020 / 16:14 IST

    Sumeet Bagadia, Executive Director at Choice Broking:

    Since last few days, the way Covid-19 cases have been rising in the country, it creates a negative sentiment in the market as India has crossed 50K Mark. At present level, the index has strong resistance at 9450 while downside good support comes at 9130-9100 level.

  • May 08, 2020 / 15:56 IST

    Vinod Nair, Head of Research at Geojit Financial Services:

    Nifty fluctuated around 150 points in another day of volatile trades, tracking uncertainty in the markets. Gains were led by Reliance, which succeeded in another round of fundraising even in this adverse scenario.

    Global market trends were also positive following attempts to defuse tensions around the US- China trade talks. While the earnings season has been lacklustre, markets seem to be awaiting announcement of a stimulus package from the government.

  • May 08, 2020 / 15:53 IST

    Sanjeev Zarbade, VP PCG Research, Kotak Securities:

    The BSE-30 Index fell 6% in the current week as market participants worried about repercussions on various sectors due to lock-down extensions offloaded their holdings.

    On the economy front, Infrastructure output, comprising eight core sectors of the IIP fell by (-) 6.5% in March as against 7.2% in February. FPIs bought equities worth USD 313 mn over the past five trading sessions while DIIs sold USD 212 mn worth of shares during the period.

  • May 08, 2020 / 15:38 IST

    Market Close:

    Benchmark indices ended higher on May 8 but profit booking in the final hour of trade pulled the Nifty below 9300.

    At close, the Sensex was up 199.32 points or 0.63% at 31642.70, and the Nifty was up 52.45 points or 0.57% at 9251.50. About 1012 shares have advanced, 1267 shares declined, and 185 shares are unchanged.

    HUL, Dr Reddy’s Labs, Tech Mahindra, Nestle and Sun Pharma were among major gainers on the Nifty, while losers included M&M, Axis Bank, NTPC, SBI and IndusInd Bank.

    Buying seen in the pharma, FMCG, energy, IT and infra space, while selling seen in the auto, bank and metal sectors.

  • May 08, 2020 / 15:30 IST

    Cyient locked in lower circuit

    Shares of Cyient were locked in 10 percent lower circuit on May 8 after weak revenue growth guidance for Q1FY21 and HDFC Securities downgraded its rating to reduce.

  • May 08, 2020 / 15:25 IST

    SBI Cards Q4

    The company has reported net profit of Rs 83.5 crore versus Rs 249 crore, while revenue was up 21% at Rs 2,510 crore versus Rs 2,076 crore, YoY, reported CNBC-TV18.

  • May 08, 2020 / 15:17 IST

    Vivimed Lab appoints CEO

    The board of directors of the company appointed Ramesh Krishnamurthy, as Chief Executive Officer (CEO) and Key Managerial Personnel (KMP) of the company with effect from 01.06.2020.

Video of the day

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347